Could an old HIV drug help fight cancer?
Disease control
Ongoing
This study tests whether adding lamivudine, an HIV drug, to standard immunotherapy can help shrink or control advanced solid tumors that have stopped responding to treatment. About 12 to 24 adults with various solid cancers will receive lamivudine alongside their current immunoth…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC